1. ALPS, FAS, and beyond: from inborn errors of immunity to acquired immunodeficiencies.
- Author
-
Consonni, Filippo, Gambineri, Eleonora, and Favre, Claudio
- Subjects
HEREDITY ,LYMPHOPROLIFERATIVE disorders ,T cells ,GENETIC variation ,IMMUNITY ,AUTOIMMUNE diseases - Abstract
Autoimmune lymphoproliferative syndrome (ALPS) is a primary immune regulatory disorder characterized by benign or malignant lymphoproliferation and autoimmunity. Classically, ALPS is due to mutations in FAS and other related genes; however, recent research revealed that other genes could be responsible for similar clinical features. Therefore, ALPS classification and diagnostic criteria have changed over time, and several ALPS-like disorders have been recently identified. Moreover, mutations in FAS often show an incomplete penetrance, and certain genotypes have been associated to a dominant or recessive inheritance pattern. FAS mutations may also be acquired or could become pathogenic when associated to variants in other genes, delineating a possible digenic type of inheritance. Intriguingly, variants in FAS and increased TCR αβ double-negative T cells (DNTs, a hallmark of ALPS) have been identified in multifactorial autoimmune diseases, while FAS itself could play a potential role in carcinogenesis. These findings suggest that alterations of FAS-mediated apoptosis could trespass the universe of inborn errors of immunity and that somatic mutations leading to ALPS could only be the tip of the iceberg of acquired immunodeficiencies. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF